Interested in this report? Get your FREE sample now! Get Sample Pages
  • Home
  •   Biotechnology
  •   Genomics Market Size, Market Share, Application Analysis, Regional Outlook, Growth, Trends, Competitive Scenario And Forecasts, 2016 To 2024

Genomics Market Size, Market Share, Application Analysis, Regional Outlook, Growth, Trends, Competitive Scenario And Forecasts, 2016 To 2024

  1. Published: August, 2014
  2. Format: Electronic (PDF)
  3. Number of pages: 100
  4. Industry: Biotechnology

Industry Insights

The global  genomics market has witnessed growth in market potential due to technological advancements such as novel informatics approach that integrate many forms of information with genomic information in disease research which allowing researchers to better understand the genetic bases of various diseases and drug response. Additionally, an increase in full reimbursement for this market by the certain governmental bodies, increasing incidence rate of fetal disorder such cancer, diabetes and others contribute to the increase in their demand  globally. Increasing usage of novel genomics techniques and tools, evaluation of their benefit to patient outcome and focusing on steps to implement it and rising genome profiling technologies are expected to grow the genomics market at the rapid speed.

Product Insights

Key genomic products include consumables, instruments and services. Consumables emerged as market leader holding the largest share of the market at 59.0% in 2013.  It is expected to grow at the fastest CAGR of over 11.0% during the forecast period due to growing commercial usage of genomic testing for varied applications clubbed with mounting applications and reduction in cost of consumer products.

Application Insights

Key application markets for genomics include diagnostics, personalizes medicine, drug discovery, academic research and others. Application of this in diagnostics market accounted for the largest overall revenue share at 35.7% in 2013.  This is due to growing application usage of molecular diagnostic tests for disease treatment and management, increasing awareness amongst medical practitioners regarding the benefits of genetics based diagnostics and accuracy.  The expected highest CAGR of personalized medicine market during the forecast period is assumed to be due to factors such as early disease prognosis, cost effective treatments, drug safety, patient compliance, and treatment optimization.  The SCGPM is striving for advancement of genomic technology for making both genetic and molecular profiling as routine tools for monitoring, disease risk prediction and treatment of diseases. North America emerged as a leader of overall personalized medicine market in 2013 due to in technology advancement and developments in the areas of genetics. Asia Pacific market of personalized medicine in 2013 is expected to grow at the highest CAGR due to development of different new technologies by research organizations leading to the improvement of the existing healthcare infrastructure and widely distributed network of clinical laboratories in India and China.

Technology Insights

Key technologies studied in this study include DNA sequencing, PCR, nucleic acid extraction and purification and DNA microarray. PCR emerged as largest market share holder segment in 2013 owing to increasing R&D activities in proteomics and genomics, technology advancement and government policies interventions regarding R&D funding. Nucleic acid extraction and purification technology market is expected to flourish at the highest CAGR of over 10.0% during the forecast period due to increasing approach for new diagnostic tools and techniques, evaluation of patient benefit  outcome and focusing on steps to increase implementation of genome profiling technologies.

Regional Insights

Europe, North America, Asia Pacific and RoW are the key regions analyzed in this report. Europe emerged as overall market leader of genomics market in 2013 owing to increasing incidence rate of genetic and cardiovascular disorders clubbed with increasing proteomics and genomics investments is expected to be driver for the market. However, regional growth is expected to be restrained owing to the presence of uneven reimbursement policies and economic crisis. The Asia Pacific market is expected to flourish at the highest CAGR of over 12.0% in 2014 to 2020 due to growing awareness and genomics techniques adoption in emerging economies such as India and China for prognosis and treatment of varied genetic disorders such as diabetes, cancer and others. Additionally, enhancing healthcare infrastructure, rising disposable incomes of patients and increasing healthcare expenditures are also growth drivers for this market.

We also offers customization on reports based on specific client requirement. Request for Customization
silent features

Choose License Type

Single User - US $2,950
Multi User - US $4,450
Enterprise User - US $5,850

Research Assistance

Steve Cooper

Research Support Specialist, USA

[email protected]


  1. Phone: +1-408-342-1548
  2. Toll Free: +1-800-489-3075
  3. Email: [email protected]
  • World's largest premium report database
  • Transparent pre & post sale customer engagement model
  • Unparalleled flexibility in terms of rendering services
  • Safe & secure web experience
  • 24*5 Research support service